Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

YouGov reiterates outlook despite 'challenging' conditions

(Sharecast News) - YouGov confirmed its full-year outlook on Friday, despite "challenging" economic conditions weighing on client budgets. Updating on interim trading, the research and analytics specialist said its performance in the six months to 31 January had been "resilient".

In particular, it noted sales momentum in the technology sector and stable demand across its data products and research divisions.

It acknowledged, however, that other sectors had been more challenging, while discretionary spend "continues to be impacted by general market softness".

It also flagged the "continued challenging macroeconomic environment".

Looking to the rest of the year, YouGov said: "The board remains cognisant of the challenging market conditions and client budget pressures as we move into the second half of the financial year."

However, it continued: "While we continue to experience long sales cycles, we remain confident in our products and sales momentum, which after a slow first quarter has significantly accelerated in the second.

"Therefore we remain confident in achieving current market expectations for the full year, underpinned by our robust sales pipeline as of January 2024."

The AIM-listed firm also gave a brief update on the acquisition of GfK's Consumer Panel Services, which completed on 9 January. YouGov said the business had been trading ahead of expectations since the deal was first announced in July, and the integration process now underway.

As at 1020 GMT, shares in YouGov were largely unchanged at 1,200p.

Share this article

Related Sharecast Articles

Celadon inks partnership with Denmark's Valeos
(Sharecast News) - Celadon Pharmaceuticals announced a strategic collaboration with Danish pharmaceutical company Valeos Pharma on Wednesday, to accelerate the production and supply of high-THC medical cannabis across Europe.
Microlise signs three new contracts
(Sharecast News) - Microlise Group announced the signing of new and expanded contracts with Goldstar Heathrow, One Stop, and Romac on Wednesday, totaling over £2m in value.
Synergia updates Cambay Field work programme
(Sharecast News) - Synergia Energy updated the market on the planned work programme for the Cambay Field production sharing contract (PSC) in Gujarat, India on Wednesday.
Manchester United full-year losses widen
(Sharecast News) - Manchester United reported a net loss of £113.2m for the year ended 30 June on Wednesday, although the football club maintained that it was in compliance with both the Premier League's Profitability and Sustainability Rules (PSR) and UEFA's Financial Fair Play regulations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.